TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07856121: The Precision Mito- Mito Map COMPASS Study

Sponsor: AI Agent Vault, Inc. d/b/a Precision Mito · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 400 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07856121 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07856121 Rescue Dossier →